Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age

Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age

Abstract Recent cancer researches pay more attention to younger patients due to the variable treatment response among different age groups. Here we investigated the effectiveness of neoadjuvant radiation on the survival of younger and older patients in stage II/III rectal cancer. Data was obtained f...

Full description

Bibliographic Details
Main Authors:	Leilei Wu, Shichao Pang, Qianlan Yao, Chen Jian, Ping Lin, Fangyoumin Feng, Hong Li, Yixue Li
Format:	Article
Language:	English
Published:	Nature Publishing Group 2017-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-02992-7

Similar Items

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy.
by: Kendrick Koo, et al.
Published: (2021-01-01)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
by: Jian Wang, et al.
Published: (2021-07-01)

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study
by: Zhiju Chen, et al.
Published: (2020-12-01)

Combination treatment of rectal cancer using polyradiomodification and short courses of neoadjuvant radiotherapy
by: Yu. A. Barsukov, et al.
Published: (2019-10-01)

Epithelial mesenchymal transition and resistance to neoadjuvant radiotherapy in locally advanced rectal cancer
by: Bhangu, Aneel
Published: (2014)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
by: Qibo Zhang, et al.
Published: (2021-01-01)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
by: Xiang-Bo Wan, et al.
Published: (2020-08-01)

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series
by: Amine Souadka, et al.
Published: (2019-10-01)

Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients
by: Feng Zhao, et al.
Published: (2020-02-01)

Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer
by: Rianne de Jong, et al.
Published: (2021-07-01)

Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
by: Mengjing Zhao, et al.
Published: (2021-01-01)

Association of markers of systemic and local inflammation with prognosis of patients with rectal cancer who received neoadjuvant radiotherapy
by: Zhang X, et al.
Published: (2018-12-01)

Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer
by: Hiroshi Doi, et al.
Published: (2021-08-01)

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
by: Hongen Xu, et al.
Published: (2019-11-01)

Comparative transcriptomics reveals specific responding genes associated with atherosclerosis in rabbit and mouse models.
by: Leilei Wu, et al.
Published: (2018-01-01)

The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age
by: Yuqiang Li, et al.
Published: (2021-07-01)

Tumor cell PD-L1 predicts poor local control for rectal cancer patients following neoadjuvant radiotherapy
by: Shao LD, et al.
Published: (2017-06-01)

Utility of neoadjuvant therapy in rectal GIST
by: Víctor López-López, et al.

Neoadjuvant Chemoradiotherapy Does Not Contribute to Worse Survival in Pathological Node-Negative Rectal Cancer
by: Yong Huang, et al.
Published: (2021-03-01)

The effect of primary tumor radiotherapy in patients with Unresectable stage IV Rectal or Rectosigmoid Cancer: a propensity score matching analysis for survival
by: Gang Wang, et al.
Published: (2020-05-01)

Preoperative radiotherapy and total neoadjuvant therapy in locally advanced rectal cancer management: So far, so good
by: Jyotiman Nath, et al.
Published: (2021-01-01)

Magnetic Resonance Image under the Low-Rank Matrix Denoising Algorithm in Evaluating the Efficacy of Neoadjuvant Chemo-Radiotherapy for Rectal Cancer
by: Cheng, G., et al.
Published: (2022)

Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer
by: Xiaolin Pang, et al.
Published: (2021-07-01)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
by: Song J, et al.
Published: (2020-08-01)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
by: Federica Papaccio, et al.
Published: (2020-12-01)

Response to neoadjuvant treatment in rectal cancer surgery
by: Loftås, Per
Published: (2016)

Assessment of the non-surgical treatment of patients with rectal cancer who underwent neoadjuvant treatment with chemotherapy and radiotherapy at the oncology department
by: Meyline Andrade Lima, et al.
Published: (2019-04-01)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
by: Edhemovic Ibrahim, et al.
Published: (2011-08-01)

Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer
by: Elisa Fontana, et al.
Published: (2021-03-01)

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
by: Pierfrancesco Franco, et al.
Published: (2018-06-01)

Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response
by: Fan Q, et al.
Published: (2021-03-01)

Oxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancer.
by: Jun Li, et al.
Published: (2014-01-01)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
by: Iacopino Bruno, et al.
Published: (2009-04-01)

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
by: Jan Poleszczuk, et al.
Published: (2017-06-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer
by: Yijun Wang, et al.
Published: (2021-03-01)

Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
by: Dan Wang, et al.
Published: (2020-05-01)

Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy
by: Pietro Valerio Foti, et al.
Published: (2016-01-01)

Correction: Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer
by: Marco Ruella, et al.
Published: (2021-06-01)

Lateral Lymph Node Metastases in Locally Advanced Low Rectal Cancers May Not Be Treated Effectively With Neoadjuvant (Chemo)Radiotherapy Only
by: Anouck Haanappel, et al.
Published: (2019-12-01)